CVS Health (CVS) — insider trading
Health Care
CVS Health (CVS) has 20 reported SEC Form 4 insider transactions in our data, including 8 open-market sales among the most recent 20 (latest 2026-06-26).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | Clark James David | Officer (SVP, Cont & Chief Acct Officer) | Shares withheld for taxes / exercise cost | 454 | $90.98 | $41.3K | Form 4 |
| 2026-05-31 | Compton-Phillips Amy | Officer (EVP, Chief Medical Officer) | Shares withheld for taxes / exercise cost | 7,618 | $90.98 | $693.1K | Form 4 |
| 2026-05-31 | Newman Brian | Officer (EVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 2,478 | $90.98 | $225.4K | Form 4 |
| 2026-05-21 | AGUIRRE FERNANDO | Director | Disposition to the issuer | 1,563 | $93.50 | $146.1K | Form 4 |
| 2026-05-21 | ROBBINS LARRY | Director | Open-market sale (derivative) | 378,000 | $93.31 | $35.27M | Form 4 |
| 2026-05-21 | ROBBINS LARRY | Director | Open-market sale | 370,462 | $93.45 | $34.62M | Form 4 |
| 2026-05-20 | AGUIRRE FERNANDO | Director | Disposition to the issuer | 30,437 | $93.78 | $2.85M | Form 4 |
| 2026-05-20 | ROBBINS LARRY | Director | Open-market sale | 800 | $96.28 | $77.0K | Form 4 |
| 2026-05-20 | ROBBINS LARRY | Director | Open-market sale | 66,881 | $95.67 | $6.40M | Form 4 |
| 2026-05-20 | ROBBINS LARRY | Director | Open-market sale | 152,691 | $94.81 | $14.48M | Form 4 |
| 2026-05-20 | ROBBINS LARRY | Director | Open-market sale | 797,628 | $93.48 | $74.56M | Form 4 |
| 2026-05-19 | ROBBINS LARRY | Director | Open-market sale | 151 | $95.18 | $14.4K | Form 4 |
| 2026-05-19 | ROBBINS LARRY | Director | Open-market sale | 1,983,387 | $94.45 | $187.33M | Form 4 |
| 2026-05-14 | SANSONE GUY P | Director | Grant / award / vesting | 1,447 | $97.15 | $140.6K | Form 4 |
| 2026-05-14 | Norwalk Leslie V | Director | Grant / award / vesting | 1,447 | $97.15 | $140.6K | Form 4 |
| 2026-05-14 | KIRBY J SCOTT | Director | Grant / award / vesting | 1,447 | $97.15 | $140.6K | Form 4 |
| 2026-05-14 | Balser Jeffrey R. | Director | Grant / award / vesting | 2,058 | $97.15 | $199.9K | Form 4 |
| 2026-05-14 | AGUIRRE FERNANDO | Director | Grant / award / vesting | 1,563 | $97.15 | $151.8K | Form 4 |
| 2026-05-14 | Mahoney Michael F | Director | Grant / award / vesting (derivative) | 1,737 | $97.15 | $168.8K | Form 4 |
| 2026-05-14 | Gallina John E | Director | Grant / award / vesting (derivative) | 1,448 | $97.15 | $140.6K | Form 4 |
Ask the chat about CVS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CVS Health (CVS).
Last updated 2026-06-26 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.